159
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Structural investigations of anthranilimide derivatives by CoMFA and CoMSIA 3D-QSAR studies reveal novel insight into their structures toward glycogen phosphorylase inhibition

, &
Pages 411-449 | Received 04 Oct 2010, Accepted 15 Dec 2010, Published online: 23 May 2011

References

  • S.J. Kenny, R.E. Aubert, and L.S. Geiss, Prevalence and incidence of non-insulin-dependent diabetes, in Diabetes in America, NIH Publication No. 95--1468, 1995, pp. 47–67
  • Landau , BR , Wahren , J , Chandramouli , V , Schumann , WC , Ekberg , K and Kalhan , SC . 1996 . Contributions of gluconeogenesis to glucose production in the fasted state . J. Clin. Invest. , 98 : 378 – 385 .
  • Treadway , JL , Mendys , P and Hoover , DJ . 2001 . Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus . Expert. Opin. Invest. Drugs , 10 : 439 – 454 .
  • Zographos , SE , Oikonomakos , NG , Tsitsanou , KE , Leonidas , DD , Chrysina , ED , Skamnaki , VT , Bischoff , H , Goldmann , S , Watson , KA and Johnson , LN . 1997 . The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor . Structure , 5 : 1413 – 1425 .
  • Lu , Z , Bohn , J , Bergeron , R , Deng , Q , Ellsworth , KP , Geissler , WM , Harris , G , McCann , PE , McKeever , B , Myers , RW , Saperstein , R , Willoughby , CA , Yao , J and Chapman , K . 2003 . A new class of glycogen phosphorylase inhibitors . Bioorg. Med. Chem. Lett. , 13 : 4125 – 4128 .
  • Kristiansen , M , Andersen , B , Iversen , LF and Westergaard , N . 2004 . Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site . J. Med. Chem. , 47 : 3537 – 3545 .
  • Pasha , FA , Chung , HW , Cho , SJ and Kang , SB . 2008 . 3D quantitative structure activity analysis and quantum chemical analysis of pyrido-di-indole . Int. J. Quant. Chem. , 108 : 391 – 400 .
  • Pasha , FA , Dal Nam , K and Cho , SJ . 2007 . CoMFA based quantitative structure toxicity relationship of azo dyes . Mol. Cell. Toxicol. , 3 : 145 – 149 .
  • Cramer , R , Patterson , D and Bunce , J . 1988 . Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins . J. Am. Chem. Soc. , 110 : 5959 – 5967 .
  • Klebe , G , Abraham , U and Meitzner , T . 1994 . Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity . J. Med. Chem. , 37 : 4130 – 4146 .
  • Sparks , SM , Banker , P , Bickett , DM , Carter , HL , Clancy , DC , Dickerson , SH , Dwornik , KA , Garrido , DM , Golden , PL , Nolte , RT , Peat , AJ , Sheckler , LR , Tavares , FX , Thomson , SA , Wang , L and Weiel , JE . 2009 . Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroup . Bioorg. Med. Chem. Lett. , 19 : 976 – 980 .
  • Sparks , SM , Banker , P , Bickett , DM , Clancy , DC , Dickerson , SH , Garrido , DM , Golden , PL , Peat , AJ , Sheckler , LR , Tavares , FX , Thomson , SA and Weiel , JE . 2009 . Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues . Bioorg. Med. Chem. Lett. , 19 : 981 – 985 .
  • Thomson , SA , Banker , P , Bickett , DM , Boucheron , JA , Carter , HL , Clancy , DC , Cooper , JP , Dickerson , SH , Garrido , DM , Nolte , RT , Peat , AJ , Sheckler , LR , Sparks , SM , Tavares , FX , Wang , L , Wang , TY and Weiel , JE . 2009 . Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy . Bioorg. Med. Chem. Lett. , 19 : 1177 – 1182 .
  • Kunick , C , Lauenroth , K , Wieking , K , Xie , X , Schultz , C , Gussio , R , Leost , D , Zaharevitz , M , Meijer , L , Weber , A , Jorgensen , FS and Lemcke , T . 2004 . Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones . J. Med. Chem. , 47 : 22 – 36 .
  • Golbraikh , A and Tropsha , A . 2002 . Beware of q2 . J. Mol. Graphics Modell. , 20 : 269 – 276 .
  • SYBYL Molecular Modeling System Version 7.1, 2005, Tripos Inc., St. Louis, MO, USA
  • Insight II 2000.1 Program, 2000, Accelrys, San Diego, CA, USA
  • FlexX, version 1.13.5, 2004, BioSolveIT GmbH, Saint Augustin, Germany
  • Rarey , M , Kramer , B , Lengauer , T and Kleb , G . 1996 . A fast flexible docking method using an incremental construction algorithm . J. Mol. Biol. , 261 : 470 – 489 .
  • Rarey , M , Wefing , S and Lengauer , T . 1996 . Placement of medium sized molecular fragments into active sites of protein . J. Comput. Aided. Mol. Des. , 10 : 41 – 54 .
  • Clark , M , Cramer , RD III and Opdenbosch , NV . 2004 . Validation of the general purpose Tripos 5. 2 force field . J. Comput. Chem. , 10 : 982 – 1012 .
  • Bush , BL and Nachbar , RB . 1993 . Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA . J. Comput. Aided. Mol. Des. , 7 : 587 – 619 .
  • Wold , S . 1978 . Cross-validation estimation of the number of components in factor and principal components analysis . Technometrics , 24 : 397 – 405 .
  • Cramer , RD , Bunce , JD , Patterson , DE and Frank , IE . 2006 . Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR Studies . Quant. Struct. Act. Relat. , 7 : 18 – 25 .
  • Clark , M , Cramer , RD III , Jones , DM , Patterson , DE and Simeroth , PE . 1990 . Comparative molecular field analysis (CoMFA), toward its use with 3D structural databases . Tetrahedron Comput. Met. , 3 : 47 – 59 .
  • Lipnick , RL . 1991 . Outliers: Their origin and use in the classification of molecular mechanics of toxicity . Sci. Total. Environ. , 109 : 131 – 153 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.